Nitric Oxide Inhibits Hepatitis B Virus Replication in the Livers of Transgenic Mice

We have previously identified two antiviral cytokines (interferon [IFN]-γ and IFN-α/β) that downregulate hepatitis B virus (HBV) replication in the liver of transgenic mice. The cytokine-inducible downstream events that inhibit HBV replication have not been identified. One possible factor is nitric oxide (NO), a pleiotropic free radical with antiviral activity that is produced in the liver by the inducible NO synthase (iNOS). To examine the role of NO in our model, we crossed transgenic mice that replicate HBV with mice that lack a functional iNOS. Importantly, iNOS-deficient mice were almost completely resistant to the noncytopathic inhibitory effect of HBV-specific cytotoxic T lymphocytes on viral replication, an effect that we have shown previously to depend on the intrahepatic induction of IFN-γ. Conversely, iNOS-deficient mice were not resistant to the antiviral effect of IFN-α/β induced by either polyinosinic-polycytidylic acid complex or by lymphocytic choriomeningitis virus (LCMV) infection. These results indicate that NO mediates the antiviral activity of IFN-γ, whereas the antiviral activity of IFN-α/β is NO independent. We also compared the relative sensitivity of LCMV to control by NO in these animals. Interestingly, LCMV replicated to higher levels in the liver of iNOS-deficient mice than control mice, indicating that NO controls LCMV replication in the liver, as well as HBV.

[1]  F. Chisari,et al.  Relative Sensitivity of Hepatitis B Virus and Other Hepatotropic Viruses to the Antiviral Effects of Cytokines , 2000, Journal of Virology.

[2]  F. Chisari,et al.  Cytokine-induced viral purging--role in viral pathogenesis. , 1999, Current opinion in microbiology.

[3]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[4]  F. Chisari,et al.  Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. , 1998, Journal of immunology.

[5]  T. Komatsu,et al.  Does Nitric Oxide Play a Critical Role in Viral Infections? , 1998, Journal of Virology.

[6]  P. Kubes,et al.  Inducible nitric oxide synthase‐deficient mice have enhanced leukocyte–endothelium interactions in endotoxemia , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  F. Chisari,et al.  Interleukin-12 inhibits hepatitis B virus replication in transgenic mice , 1997, Journal of virology.

[8]  P. Kubes,et al.  Role of nitric oxide in regulation of leucocyte‐endothelial cell interactions , 1997, Experimental physiology.

[9]  F. Chisari,et al.  Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  F. Chisari,et al.  Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.

[11]  E. Borden,et al.  An overview of the interferon system: signal transduction and mechanisms of action. , 1996, Cancer investigation.

[12]  F. Chisari,et al.  High-level hepatitis B virus replication in transgenic mice , 1995, Journal of virology.

[13]  C. Nathan,et al.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.

[14]  P. Kubes,et al.  Nitric oxide is an antiadhesive molecule for leukocytes. , 1995, New horizons.

[15]  C. Chiang,et al.  Expression of the inducible nitric oxide synthase. Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. , 1994, Journal of immunology.

[16]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[17]  R. Zinkernagel,et al.  Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon , 1994, Journal of virology.

[18]  C. Lowenstein,et al.  Nitric Oxide: A Physiologic Messenger , 1994, Annals of Internal Medicine.

[19]  F. Chisari,et al.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.

[20]  H. Lother,et al.  Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus‐infected mice with anti‐interferon‐γ monoclonal antibody blocks generation of virus‐specific cytotoxic T lymphocytes and virus elimination , 1989, European journal of immunology.

[21]  R. Zinkernagel,et al.  Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice , 1989, Journal of virology.